Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
842 hedge funds and large institutions have $65B invested in Allergan plc in 2014 Q4 according to their latest regulatory filings, with 151 funds opening new positions, 317 increasing their positions, 288 reducing their positions, and 56 closing their positions.
170% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 56
70% more call options, than puts
Call options by funds: $3.07B | Put options by funds: $1.81B
16% more capital invested
Capital invested by funds: $55.9B → $65B (+$9.11B)
12% more funds holding
Funds holding: 754 → 842 (+88)
10% more repeat investments, than reductions
Existing positions increased: 317 | Existing positions reduced: 288
10% more funds holding in top 10
Funds holding in top 10: 113 → 124 (+11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.66B |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$853M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$509M |
| 4 |
Jennison Associates
New York
|
+$464M |
| 5 |
MCM
Marsico Capital Management
Denver,
Colorado
|
+$317M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$598M |
| 2 |
SC
Sculptor Capital
New York
|
-$373M |
| 3 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$261M |
| 4 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$250M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$226M |
AGN Hedge Fund Activity: Q4 2014 in Review
842 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2014, worth a combined $65B — up 16% from $55.9B a quarter earlier.
Buyers outnumbered sellers: 151 funds opened new AGN positions and 56 closed out — a net gain of 95 holders — while 317 added to existing stakes and 288 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.66B. The largest seller was Lone Pine Capital, exiting entirely with an estimated $598M sold.
- 842 institutional investors held Allergan plc (AGN) as of Q4 2014, up from 754 in Q3 2014.
- Funds reported $65B of Allergan plc stock for Q4 2014, up 16% quarter-over-quarter.
- 151 funds opened new Allergan plc positions in Q4 2014 and 56 closed out, a net change of +95 holders.
- The largest Allergan plc buyer in Q4 2014 was T. Rowe Price Associates, an estimated $1.66B added.
- The largest Allergan plc seller in Q4 2014 was Lone Pine Capital, an estimated $598M sold.
Based on aggregated 13F filings for Q4 2014.